CIK 0001664710
- Non-accelerated filer
- Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811173868
- Phone
- +1 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,619
- in 1 filing, $6K under 10b5-1 plans
Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-11 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −2,650 | 132,355 | ||
| 2021-05-04 | Knowles Julius Director | Sale | −1,196 | $53.73 | $64K | 572,825 |
| 2021-05-04 | Knowles Julius Director | Sale | −780 | $53.73 | $42K | 383,544 |
| 2021-05-04 | Knowles Julius Director | Sale | −520 | $54.35 | $28K | 572,305 |
| 2021-05-04 | Knowles Julius Director | Sale | −339 | $54.35 | $18K | 383,205 |
| 2021-05-03 | Knowles Julius Director | Sale | −5,383 | $56.04 | $302K | 595,763 |
| 2021-05-03 | Knowles Julius Director | Sale | −3,509 | $56.04 | $197K | 398,506 |
| 2021-05-03 | Knowles Julius Director | Sale | −6,841 | $56.63 | $387K | 588,922 |
| 2021-05-03 | Knowles Julius Director | Sale | −4,460 | $56.63 | $253K | 394,046 |
| 2021-05-03 | Knowles Julius Director | Sale | −7,054 | $57.86 | $408K | 581,868 |
| 2021-05-03 | Knowles Julius Director | Sale | −4,600 | $57.86 | $266K | 389,446 |
| 2021-05-03 | Knowles Julius Director | Sale | −6,905 | $58.78 | $406K | 574,963 |
| 2021-05-03 | Knowles Julius Director | Sale | −4,506 | $58.78 | $265K | 384,940 |
| 2021-05-03 | Knowles Julius Director | Sale | −942 | $59.48 | $56K | 574,021 |
| 2021-05-03 | Knowles Julius Director | Sale | −616 | $59.48 | $37K | 384,324 |
| 2021-04-12 | Ordonez Claudia Chief Medical Officer | Exercise or conversion | +1,000 | $0.48 | $480 | 1,000 |
| 2021-04-12 | Ordonez Claudia Chief Medical Officer | Sale | −400 | $59.09 | $24K | 600 |
| 2021-04-12 | Ordonez Claudia Chief Medical Officer | Sale | −367 | $60.01 | $22K | 233 |
| 2021-04-12 | Ordonez Claudia Chief Medical Officer | Sale | −233 | $61.23 | $14K | 0 |
| 2021-04-12 | Ordonez Claudia Chief Medical Officer | Exercise or conversion · Employee Stock Option (right to buy) | −1,000 | 100,211 |
Page 21 of 36 · 707 trades